Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia
Disease Models & Mechanisms · 2023
DOI: 10.1242/dmm.049861 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease Models & Mechanisms, 2023. Verfasst von Leonard D Kuhrt und 14 weiteren Autor:innen. Beteiligte Einrichtung: Cellular Neurosciences, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, 13125 Berlin, Germany. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Neurofibromatosis 1, Neurofibromin 1. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NCI NIH HHS, NIH HHS.
Abstract (Originalsprache)
Neurofibromatosis type 1 (NF1) is an autosomal dominant condition caused by germline mutations in the neurofibromin 1 (NF1) gene. Children with NF1 are prone to the development of multiple nervous system abnormalities, including autism and brain tumors, which could reflect the effect of NF1 mutation on microglia function. Using heterozygous Nf1-mutant mice, we previously demonstrated that impaired purinergic signaling underlies deficits in microglia process extension and phagocytosis in situ. To determine whether these abnormalities are also observed in human microglia in the setting of NF1, we leveraged an engineered isogenic series of human induced pluripotent stem cells to generate human microglia-like (hiMGL) cells heterozygous for three different NF1 gene mutations found in patients with NF1. Whereas all NF1-mutant and isogenic control hiMGL cells expressed classical microglia markers and exhibited similar transcriptomes and cytokine/chemokine release profiles, only NF1-mutant hiMGL cells had defects in P2X receptor activation, phagocytosis and motility. Taken together, these findings indicate that heterozygous NF1 mutations impair a subset of the functional properties of human microglia, which could contribute to the neurological abnormalities seen in children with NF1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cellular Neurosciences, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, 13125 Berlin, Germany.
- Technology Platform Pluripotent Stem Cells, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, 13125 Berlin, Germany.
- Charité - Universitätsmedizin Berlin, Berlin, Germany.
- Department of Neurosurgery, University Medical Center Schleswig-Holstein, 24105 Kiel, Germany.
- German Cancer Consortium (DKTK), Clinical Cooperation Unit (CCU), Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
- Department of Neurology, Medical Faculty Mannheim (MCTN), University of Heidelberg, 68167 Mannheim, Germany.
ORCID-Profile: Leonard D Kuhrt, Corina Anastasaki, David H Gutmann, Helmut Kettenmann
Förderung
- NINDS NIH HHS
- NCI NIH HHS
- NIH HHS
- NeuroCure Exzellenzcluster
- National Institutes of Health
- Berlin Institute of Health
- Einstein Stiftung Berlin
- Shenzhen Key Laboratory of Neuroimmunomodulation for Neurological Diseases
Zitieren
APA
Kuhrt, L. D., Motta, E., Elmadany, N., Weidling, H., Fritsche-Guenther, R., Efe, I. E., Cobb, O., Chatterjee, J., Boggs, L. G., Schnauß, M., Diecke, S., Semtner, M., Anastasaki, C., Gutmann, D. H., & Kettenmann, H. (2023). Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.049861
Vancouver
Kuhrt LD, Motta E, Elmadany N, Weidling H, Fritsche-Guenther R, Efe IE, et al. Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia. Disease Models & Mechanisms. 2023. doi:10.1242/dmm.049861
BibTeX
@article{Kuhrt2023,
author = {Kuhrt, Leonard D and Motta, Edyta and Elmadany, Nirmeen and Weidling, Hannah and Fritsche-Guenther, Raphaela and Efe, Ibrahim E and Cobb, Olivia and Chatterjee, Jit and Boggs, Lucy G and Schnauß, Marina and Diecke, Sebastian and Semtner, Marcus and Anastasaki, Corina and Gutmann, David H and Kettenmann, Helmut},
title = {Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia},
journal = {Disease Models & Mechanisms},
year = {2023},
doi = {10.1242/dmm.049861}
}
EUVIMED